Seven One Seven Capital Management Horizon Therapeutics Public LTD CO Transaction History

Seven One Seven Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $319,235 - $388,388	-3,239 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $6,157 - $7,394	67 Added 2.11%	3,239 $355,000
Q2 2021 Aug 13, 2021	BUY	$86.24 - $95.92 $65,197 - $72,515	756 Added 31.29%	3,172 $297,000
Q1 2021 May 13, 2021	BUY	$71.83 - $95.48 $173,541 - $230,679	2,416 New	2,416 $222,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Seven One Seven Capital Management, based on Form 13F filings with the SEC.

Stay updated on Seven One Seven Capital Management with notifications on news.